Home Subscription Services
 
   

 
Oral Biosciences & Medicine
OBM Home Page
About the Editor
Editorial Board
Submit
Author Guidelines
Submission Form
Reprints / Articles
Permissions
Advertising
MEDLINE Search
 
 
 
 
 
FacebookTwitterYouTube
Quintessence Publishing: Journals: OBM

 

Oral Biosciences & Medicine

Edited by Birgitte Nauntofte, Jesper Reibel. Peter A. Reichart, Jim Sciubba, and Joanna M. Zakrzewska

Official publication of the European Society for Oral Laser Applications

ISSN 1742-3287

Publication:
Oral Biosciences & Medicine

Year 2005
Volume 2 , Issue 1

Back
Pages: 21 - 27

The Clinical Phenotype of Pemphigus Vulgaris Correlates to the Anti-Desmoglein Antibody Levels: The First Study Performed in Greece

Sklavounou-Andrikopoulou, Alexandra/Iakovou, Maria/Tsirogianni, Alexandra/Analiti, Chara/Michelaki, Irene/Papasteriadi, Chrysa/Papanikolaou, Stavros/Perissios, Andreas

Purpose: The aim of the present study was to evaluate the levels of circulating antibodies against desmoglein (Dgs) 1 and Dgs3 in serum samples from patients with pemphigus vulgaris (PV) and correlate these values to the clinical phenotype of the disease. Materials and Methods: Serum samples were obtained from 25 patients with oral mucosal dominant PV (group II), 23 patients with mucocutaneous PV (group III), 15 PV patients free of clinical symptoms (group I) and 30 healthy donors. Antibody titres against Dgs1 and Dgs3 were measured with enzyme-linked immunoabsorbent assay (ELISA) using recombinant Dsg1 and Dsg3. The relationship between the clinical phenotype and Dgs1 or Dgs3 levels was examined using ordinal logistic regression. Results: Serum samples from groups I and II were positive for antibodies against Dgs3. Positive anti-Dsg3 and anti-Dgs1 antibodies were detected in the mucocutaneous PV group. Antibody titres against Dsg3 correlated with the serum circulating antibodies and the disease progression. Dgs1 levels and clinical phenotype were not significantly associated. Conclusions: The clinical phenotype of the disease is defined by the anti-Dsg autoantibody profile whereas the measurement of the anti-Dsg3 autoantibody levels should be considered as a reliable indicator of disease progression.

Keywords: pemphigus vulgaris, desmoglein 1, desmoglein 3, clinical phe

 

  © 2014 Quintessence Publishing Co Inc
 

Home | Subscription Services | Books | Journals | Multimedia | Events | Blog
Terms of Use | Privacy Policy | About Us | Contact Us | Advertising | Help | Sitemap | Catalog